Lopez M - Search Results

1

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

2

Chemotherapy in metastatic male breast cancer.

Lopez M, Di Lauro L, Papaldo P, Lazzaro B. Lopez M, et al. Oncology. 1985;42(4):205-9. doi: 10.1159/000226032. Oncology. 1985. PMID: 4011106

3

Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.

Lopez M, Vici P, Di Lauro L, Paoletti G, Gionfra T, Conti F, Carpano S, Pignatti F, Giannarelli D. Lopez M, et al. Eur J Cancer. 1995 Sep;31A(10):1611-4. doi: 10.1016/0959-8049(95)00200-3. Eur J Cancer. 1995. PMID: 7488410 Clinical Trial.

4

Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.

Di Lauro L, Del Medico P, Carpano S, Cancrini A, Gionfra T, Vici P, Rosselli M, Lopez M. Di Lauro L, et al. Among authors: lopez m. Tumori. 1995 Jan-Feb;81(1):42-4. doi: 10.1177/030089169508100110. Tumori. 1995. PMID: 7754540 Clinical Trial.

5

Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.

Lopez M, Natali M, Di Lauro L, Vici P, Pignatti F, Carpano S. Lopez M, et al. Cancer. 1993 Jul 15;72(2):502-5. doi: 10.1002/1097-0142(19930715)72:2<502::aid-cncr2820720228>3.0.co;2-1. Cancer. 1993. PMID: 8319180

6

Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.

Vici P, Di Lauro L, Carpano S, Amodio A, Pignatti F, Casali A, Conti F, Lopez M. Vici P, et al. Among authors: lopez m. Oncology. 1996 Jan-Feb;53(1):16-8. doi: 10.1159/000227528. Oncology. 1996. PMID: 8570125 Clinical Trial.

7

Paclitaxel activity in anthracycline refractory breast cancer patients.

Vici P, Di Lauro L, Conti F, Capomolla E, Gionfra T, Amodio A, Lopez M. Vici P, et al. Among authors: lopez m. Tumori. 1997 May-Jun;83(3):661-4. doi: 10.1177/030089169708300307. Tumori. 1997. PMID: 9267484 Clinical Trial.

8

European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity.

Lopez M, Vici P. Lopez M, et al. Semin Oncol. 1998 Aug;25(4 Suppl 10):55-60. Semin Oncol. 1998. PMID: 9768825 Review.

9

First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.

Vici P, Amodio A, Di Lauro L, Conti F, Gionfra T, Belli F, Lopez M. Vici P, et al. Among authors: lopez m. Oncology. 2000;58(1):3-7. doi: 10.1159/000012071. Oncology. 2000. PMID: 10644933 Clinical Trial.

10

Docetaxel in patients with anthracycline-resistant advanced breast cancer.

Vici P, Belli F, Di Lauro L, Amodio A, Conti F, Foggi P, Gionfra T, Morelli MF, Botti C, Ferraironi A, Lopez M. Vici P, et al. Among authors: lopez m. Oncology. 2001;60(1):60-5. doi: 10.1159/000055298. Oncology. 2001. PMID: 11150910 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,464 results

Search Page

Filters